This book provides an overview of the molecular aspects and pathogenesis of haematologic malignancies and available targeted therapies and immune therapeutic approaches in each type of the disease. Active clinical trials for each product are also collected and adverse events associated with each medicine are also discussed in detail. It should be noted that therapeutic approaches in haematologic malignancies are among the fast-paced study fields in medicine and the approval of each medicinal product and the indications are subject to change.

Skilled, hard-working and meticulous drug safety professional, with contribution in developing and performing all aspects of safety management. Has been globally and domestically responsible for implementing and and following USFDA, ICH guidelines, EMEA/EU regulations. Fully compliant with timelines, report submissions, review of source documents.